Is PEA Safe for Children? What the Pediatric IBS Trial Shows
One randomized trial gave PEA with polydatin to 70 children aged 10 to 17 for 12 weeks. What it found on symptoms and safety, and what it cannot tell parents.
One randomized trial gave PEA with polydatin to 70 children aged 10 to 17 for 12 weeks. What it found on symptoms and safety, and what it cannot tell parents.
Does PEA stop working over time? What tolerance and tachyphylaxis mean, and why the research points the opposite direction for long-term use.
When to take palmitoylethanolamide timing: practical guidance on food co-ingestion, daily dosing windows, and absorption, what current evidence supports.
Explore how palmitoylethanolamide (PEA) may combine with luteolin, omega-3s, and other supplements: mechanisms, practical considerations, and honest caveats.
A review of clinical trial and systematic review data on palmitoylethanolamide (PEA) side effects, tolerability, and who should exercise caution.
PEA safety in pregnancy and breastfeeding: what preclinical data, breast milk research, and critical evidence gaps actually show.
PEA dosage explained: the ranges used for chronic pain, when to take it, how micronized and ultramicronized forms differ, and the safety notes.
What does the research actually say about palmitoylethanolamide drug interactions? An honest, evidence-based look at PEA and medications.
Micronized and ultramicronized PEA differ meaningfully in particle size and dissolution rate. Here is what the research evidence actually shows about each form.
How long does palmitoylethanolamide take to work? Clinical evidence points to 4 to 12 weeks for chronic conditions, with acute pain responding sooner.